basal ganglia disease |
Disease ID | 1042 |
---|---|
Disease | basal ganglia disease |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:2) |
Disease ID | 1042 |
---|---|
Disease | basal ganglia disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:1) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:45) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0004782 | amitriptyline | D000639 | 50-48-6 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11075569 | ||
C0004782 | amlodipine | D017311 | 88150-42-9 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11075569 | ||
C0004782 | amoxapine | D000657 | 14028-44-5 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 2864332 | ||
C0004782 | buspirone | D002065 | 36505-84-7 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 17351421 | ||
C0004782 | caffeine | D002110 | 1958/8/2 | basal ganglia diseases | MESH:D001480 | therapeutic | 18594798 | ||
C0004782 | carbamazepine | D002220 | 298-46-4 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 20375657 | ||
C0004782 | chloroquine | D002738 | 1954/5/7 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 457222 | ||
C0004782 | chlorpromazine | D002746 | 50-53-3 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11549212 | ||
C0004782 | chlorpromazine | D002746 | 50-53-3 | basal ganglia diseases | MESH:D001480 | therapeutic | 5781950 | ||
C0004782 | cimetidine | D002927 | 51481-61-9 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 7134098 | ||
C0004782 | cinnarizine | D002936 | 298-57-7 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10390751 | ||
C0004782 | clozapine | D003024 | 5786-21-0 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10852089 | ||
C0004782 | droperidol | D004329 | 548-73-2 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10411778 | ||
C0004782 | fluoxetine | D005473 | 54910-89-3 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11448089 | ||
C0004782 | fluvoxamine | D016666 | 54739-18-3 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 1583525 | ||
C0004782 | haloperidol | D006220 | 52-86-8 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10468313 | ||
C0004782 | haloperidol | D006220 | 52-86-8 | basal ganglia diseases | MESH:D001480 | therapeutic | 9179395 | ||
C0004782 | ifosfamide | D007069 | 3778-73-2 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 2049756 | ||
C0004782 | imipramine | D007099 | 50-49-7 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 1786266 | ||
C0004782 | imipramine | D007099 | 50-49-7 | basal ganglia diseases | MESH:D001480 | therapeutic | 4671924 | ||
C0004782 | indinavir | D019469 | 150378-17-9 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11978161 | ||
C0004782 | ketorolac | D020910 | 66635-83-4 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11869410 | ||
C0004782 | lamotrigine | C047781 | 84057-84-1 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 19681008 | ||
C0004782 | lansoprazole | D064747 | - | basal ganglia diseases | MESH:D001480 | marker/mechanism | 15037850 | ||
C0004782 | loxapine | D008152 | 1977/10/2 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 7028656 | ||
C0004782 | methylphenidate | D008774 | 113-45-1 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11869410 | ||
C0004782 | morphine | D009020 | 57-27-2 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10411778 | ||
C0004782 | nizatidine | D016567 | 76963-41-2 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 15303455 | ||
C0004782 | nortriptyline | D009661 | 72-69-5 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10435776 | ||
C0004782 | olanzapine | C076029 | 132539-06-1 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10436199 | ||
C0004782 | phenytoin | D010672 | 57-41-0 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 12940655 | ||
C0004782 | phenytoin | D010672 | 57-41-0 | basal ganglia diseases | MESH:D001480 | therapeutic | 4075309 | ||
C0004782 | pilocarpine | D010862 | 92-13-7 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 1756784 | ||
C0004782 | prochlorperazine | D011346 | 58-38-8 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10881788 | ||
C0004782 | procyclidine | D011352 | 77-37-2 | basal ganglia diseases | MESH:D001480 | therapeutic | 6016862 | ||
C0004782 | propranolol | D011433 | 525-66-6 | basal ganglia diseases | MESH:D001480 | therapeutic | 12900300 | ||
C0004782 | pyridoxine | D011736 | - | basal ganglia diseases | MESH:D001480 | marker/mechanism | 872535 | ||
C0004782 | ritonavir | D019438 | - | basal ganglia diseases | MESH:D001480 | marker/mechanism | 11978161 | ||
C0004782 | sulpiride | D013469 | 15676-16-1 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 622221 | ||
C0004782 | thiethylperazine | D013847 | 1420-55-9 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 16101941 | ||
C0004782 | triflupromazine | D014273 | 146-54-3 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 936714 | ||
C0004782 | trihexyphenidyl | D014282 | 144-11-6 | basal ganglia diseases | MESH:D001480 | therapeutic | 11532387 | ||
C0004782 | valproic acid | D014635 | 99-66-1 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 10435776 | ||
C0004782 | vigabatrin | D020888 | 60643-86-9 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 18783433 | ||
C0004782 | ziprasidone | C092292 | 146939-27-7 | basal ganglia diseases | MESH:D001480 | marker/mechanism | 15465997 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |